Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-05-19

Clinical Trial Update: Comparison of Efficacy and Safety of Norgestimate-ethinyl Estradiol and Cyproterone Acetate-ethinyl Estradiol in the Treatment of Acne Vulgaris [Phase 4]

View source ↗

Summary

Phase 4 trial comparing the efficacy and safety of norgestimate/ethinyl estradiol versus cyproterone acetate/ethinyl estradiol for acne vulgaris; study complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cyproterone acetate-ethinyl estradiol (cyproterone acetate/ethinyl estradiol)
  • Norgestimate/Ethinyl Estradiol (Norgestimate and Ethinyl Estradiol)

Snippet

Sponsor: Johnson & Johnson Taiwan Ltd | Conditions: Acne Vulgaris | Phase 4 | Status: COMPLETED